TipRanks
Advertisement
Advertisement

XTLB Stock Latest News

XTL Biopharmaceuticals Moves to Replace Resigning External Director
Company AnnouncementsXTL Biopharmaceuticals Moves to Replace Resigning External Director
51s ago
6K
XTLB
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition
PremiumCompany Announcements
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition
2M ago
6K
XTLB
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period
PremiumCompany Announcements
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period
3M ago
6K
XTLB
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine
PremiumCompany Announcements
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine
4M ago
6K
XTLB
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase
PremiumCompany Announcements
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase
4M ago
6K
XTLB
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026
PremiumCompany AnnouncementsXTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026
4M ago
6K
XTLB
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
Premium
Company Announcements
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
5M ago
6K
XTLB
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
Premium
Company Announcements
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
5M ago
6K
XTLB
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
PremiumCompany Announcements
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
5M ago
6K
XTLB
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
PremiumCompany Announcements
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
6M ago
XTLB
3 Penny Stocks to Watch Now, 4/30/26
PremiumMarket News
3 Penny Stocks to Watch Now, 4/30/26
6M ago
AKAN
RDAC
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
PremiumCompany Announcements
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
6M ago
6K
XTLB
XTL Biopharmaceuticals to acquire Psyga Bio
PremiumThe FlyXTL Biopharmaceuticals to acquire Psyga Bio
6M ago
XTLB
XTL Biopharmaceuticals trading halted, news pending
Premium
The Fly
XTL Biopharmaceuticals trading halted, news pending
7M ago
XTLB
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
7M ago
AZI
JFB
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
PremiumCompany Announcements
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
7M ago
6K
XTLB
XTL Biopharmaceuticals announces ADS ratio change
PremiumThe Fly
XTL Biopharmaceuticals announces ADS ratio change
7M ago
XTLB
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
PremiumCompany Announcements
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
7M ago
6K
XTLB
Beyond Air announces termination of NeuroNOS agreement with XTL
PremiumThe Fly
Beyond Air announces termination of NeuroNOS agreement with XTL
7M ago
XAIR
XTLB
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination
PremiumCompany AnnouncementsXTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination
8M ago
6K
XTLB
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
Premium
The Fly
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
8M ago
XTLB
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
Premium
Company Announcements
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
8M ago
6K
XTLB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >